Literature DB >> 22863580

[Role of let-7 in maintaining characteristics of breast cancer stem cells].

Xin Sun1, Chong Fan, Li-juan Hu, Ning Du, Chong-wen Xu, Hong Ren.   

Abstract

AIM: To observe the expression of let-7 in breast cancer stem cells and explore the role of let-7 in maintaining the characteristics of breast cancer stem cells.
METHODS: We separated breast cancer stem cells (SP and NSP) from MCF-7 cell line using SP sorting, and observed the expression of let-7a/b/c on SP and NSP cells using quantitative real-time PCR and the expressions of Ras and ERK using Western blotting to study the mechanism by which let-7 maintains the characteristics of breast cancer stem cells.
RESULTS: The SP cells accounted for 3.3% in MCF-7 cells, however, the rate dropped to 0.4% when verapamil was added into the process of seperation. The level of Let-7a/b/c in SP cells were lower than that in NSP cells, and among let-7 miRNAs, let-7b/c showed the most obvious difference. The expressions of t-Ras and t-ERK showed no difference between SP and NSP cells, nevertheless, the expressions of p-Ras, p-ERK were higher in SP cells than in NSP cells.
CONCLUSION: SP sorting is an effective method to separate cancer stem cells. There do exist cancer stem cells in MCF-7 breast cancer cell line. Let-7 is down-regulated in SP cells, and the down-regulation makes let-7 lose the opportunity to restrain Ras mRNA, finally, p-Ras and p-ERK are activated. They play an important role in maintaining the characteristics of breast cancer stem cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22863580

Source DB:  PubMed          Journal:  Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi        ISSN: 1007-8738


  9 in total

1.  MicroRNAs and cancer: Key paradigms in molecular therapy.

Authors:  Weige Tan; Bodu Liu; Shaohua Qu; Gehao Liang; Wei Luo; Chang Gong
Journal:  Oncol Lett       Date:  2017-12-19       Impact factor: 2.967

2.  Let-7c blocks estrogen-activated Wnt signaling in induction of self-renewal of breast cancer stem cells.

Authors:  X Sun; C Xu; S-C Tang; J Wang; H Wang; P Wang; N Du; S Qin; G Li; S Xu; Z Tao; Dapeng Liu; H Ren
Journal:  Cancer Gene Ther       Date:  2016-03-18       Impact factor: 5.987

Review 3.  MicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potential.

Authors:  Wei Wang; Yun-ping Luo
Journal:  J Zhejiang Univ Sci B       Date:  2015-01       Impact factor: 3.066

Review 4.  Emerging ways to treat breast cancer: will promises be met?

Authors:  Pouria Samadi; Sahar Saki; Fatemeh Karimi Dermani; Mona Pourjafar; Massoud Saidijam
Journal:  Cell Oncol (Dordr)       Date:  2018-09-27       Impact factor: 6.730

Review 5.  MicroRNAs, a Promising Target for Breast Cancer Stem Cells.

Authors:  Plabon Kumar Das; Mst Ayesha Siddika; Saharia Yeasmin Asha; Suraiya Aktar; Md Abdur Rakib; Jahan Ara Khanam; Suja Pillai; Farhadul Islam
Journal:  Mol Diagn Ther       Date:  2020-02       Impact factor: 4.074

Review 6.  Side population cells as prototype of chemoresistant, tumor-initiating cells.

Authors:  Vinitha Richard; Madhumathy G Nair; T R Santhosh Kumar; M Radhakrishna Pillai
Journal:  Biomed Res Int       Date:  2013-11-04       Impact factor: 3.411

7.  Differential microRNA expression profiles in tamoxifen-resistant human breast cancer cell lines induced by two methods.

Authors:  Peng Ye; Cheng Fang; Hui Zeng; Yu Shi; Zhongya Pan; Nairui An; Keli He; Li Zhang; Xinghua Long
Journal:  Oncol Lett       Date:  2018-01-10       Impact factor: 2.967

8.  Let-7a suppresses Ewing sarcoma CSCs' malignant phenotype via forming a positive feedback circuit with STAT3 and lin28.

Authors:  Jiang Xu; Zhongzu Zhang; Lu Huang; Jiachao Xiong; Zhenhai Zhou; Honggui Yu; Liang Wu; Zhimin Liu; Kai Cao
Journal:  J Bone Oncol       Date:  2021-11-30       Impact factor: 4.072

9.  Nutlin-3-Induced Sensitization of Non-Small Cell Lung Cancer Stem Cells to Axitinib-Induced Apoptosis Through Repression of Akt1/Wnt Signaling.

Authors:  Meng Wang; Xin Wang; Yuan Li; Qiang Xiao; Xiao-Hai Cui; Guo-Dong Xiao; Ji-Chang Wang; Chong-Wen Xu; Hong Ren; Dapeng Liu
Journal:  Oncol Res       Date:  2019-03-04       Impact factor: 5.574

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.